Cerenome (PSTV) Other Non-Current Liabilities (2010 - 2025)
Plus Therapeutics (PSTV) posted quarterly Other Non-Current Liabilities of $25.1 million for Q1 2025, up 2513700.0% quarter-over-quarter from $1000.0 in Q4 2021.
Cerenome (PSTV) Other Non-Current Liabilities (2010 - 2025) Analysis & Trends
Plus Therapeutics (PSTV) has reported Other Non-Current Liabilities for 12 consecutive years, with $25.1 million the latest figure, recorded in Q1 2025.
- In Q1 2025, Other Non-Current Liabilities changed N/A year-over-year to $25.1 million; the TTM figure through Mar 2025 stood at $25.1 million (changed N/A YoY), while the FY2021 annual figure was $1000.0, down 85.71% from the prior year.
- Other Non-Current Liabilities advanced to $25.1 million in Q1 2025 per PSTV's latest filing, from $1000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $25.1 million in Q1 2025 and bottomed at $1000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 25.14 Mn |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 5,000.00 |
| Dec 31, 2020 | 7,000.00 |
| Sep 30, 2020 | 4.50 Mn |
| Jun 30, 2020 | 242,000.00 |
| Mar 31, 2020 | 8,000.00 |
| Dec 31, 2019 | 6.93 Mn |
| Sep 30, 2019 | 38,000.00 |
| Jun 30, 2019 | 65,000.00 |
| Mar 31, 2019 | 706,000.00 |
| Dec 31, 2018 | 46,000.00 |
| Sep 30, 2018 | 1.47 Mn |
| Sep 30, 2016 | 5.90 Mn |
| Jun 30, 2016 | 5.90 Mn |
| Mar 31, 2016 | 5.10 Mn |
| Sep 30, 2015 | 7.60 Mn |
| Jun 30, 2015 | 9.20 Mn |